Abstract
Genetic Engineering & Biotechnology NewsVol. 42, No. 4 OMICSNGS Upstarts Expected to Take On the ChampionSan Diego–based Illumina, long the dominant player in NGS technology, faces competition from crosstown rivals Element Biosciences and Singular GenomicsJulianna LeMieux, PhDJulianna LeMieux, PhDSearch for more papers by this authorPublished Online:5 Apr 2022https://doi.org/10.1089/gen.42.04.09AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 4Apr 2022 Information© 2022 by GEN PublishingTo cite this article:Julianna LeMieux, PhD.NGS Upstarts Expected to Take On the Champion.Genetic Engineering & Biotechnology News.Apr 2022.22-25.http://doi.org/10.1089/gen.42.04.09Published in Volume: 42 Issue 4: April 5, 2022PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
